CURRENTLY SOLD OUT
About this product
Product Information
Progress and Challenges in Precision Medicine presents an insightful overview to the myriad factors of personalized and precision medicine. The availability of the human geme, large amounts of data on individual genetic variations, environmental interactions, influence of lifestyle, and cutting-edge tools and techlogies for big-data analysis have led to the age of personalized and precision medicine. Bringing together a global range of experts on precision medicine, this book collects previously scattered information into one concise volume which covers the most important developments so far in precision medicine and also suggests the most likely avenues for future development. The book includes clinical information, informatics, public policy implications, and information on case studies. It is a useful reference and background work for students, researchers, and clinicians working in the biomedical and medical fields, as well as policymakers in the health sciences.Product Identifiers
PublisherAcademic Press Inc, Elsevier Science Publishing Co Inc
ISBN-100128094117
ISBN-139780128094112
eBay Product ID (ePID)230862024
Product Key Features
SubjectClinical Medicine: Professional
LanguageEnglish
FormatPaperback
Dimensions
Height229mm
Width152mm
Weight540g
Additional Product Features
Date of Publication09/01/2017
Place of PublicationSan Diego
GenreClinical Medicine: Professional
Country of PublicationUnited States
Edited byMukesh Verma, Debmalya Barh
Author BiographyDr. Mukesh Verma is a Program Director and Chief in the Methods and Technologies Branch (MTB), Epidemiology and Genetics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), National Institutes of Health (NIH). Before coming to the DCCPS, he was a Program Director in the Division of Cancer Prevention (DCP), NCI, providing direction in the areas of biomarkers, early detection, risk assessment and prevention of cancer, epigenetics, epidemiology, and cancers associated with infectious agents. Since joining the NCI, he has sought to champion the visibility of and investment in cancer epigenetics research both within the Institute and across other federal and non-governmental agencies, and to raise public awareness about controlling cancer. He represents NIH in Common Fund Programs on Epigenomics, Metabolomics, and Molecular Transducers of Physical Activity. Dr. Mukesh Verma holds a M.Sc. from Pantnagar University and a Ph.D. from Banaras Hindu University. He did postdoctoral research at George Washington University and was a faculty member at Georgetown University Medical Center. He has published 161 research articles and reviews and edited five books in cancer biomarkers, epigenetics and epidemiology field. Dr. Barh is a MSc (Applied Genetics), MTech & MPhil-(Biotechnology), PhD (Genomics), PhD (Biotechnology) and Post Graduate in Management. He has over 15 years leading healthcare, molecular diagnostic, bioinformatics industry and academic research experience in the field of integrative omics-based biomarkers, targets, targeted drugs, precision diagnosis, and personalized and predictive medicine in cancers and various complex diseases. Dr. Barh has edited 15+ cutting-edge research reference books in the field of omics and is a regular reviewer of various leading journals published by Nature publications, Biomed Central (BMC), PLOS etc. Due to his significant contribution in the field, he has been recognized by Who's Who in the World and Limca Book of Records. He is also the editor of the forthcoming Elsevier title Omics Technologies and Bio-Engineering (Jan 2017).
